198 related articles for article (PubMed ID: 35478057)
1. Mutation in SF3B1 gene promotes formation of polyploid giant cells in Leukemia cells.
Mukherjee S; Ali AM; Murty VV; Raza A
Med Oncol; 2022 Apr; 39(5):65. PubMed ID: 35478057
[TBL] [Abstract][Full Text] [Related]
2. Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs).
Bowers RR; Andrade MF; Jones CM; White-Gilbertson S; Voelkel-Johnson C; Delaney JR
BMC Cancer; 2022 Apr; 22(1):410. PubMed ID: 35421971
[TBL] [Abstract][Full Text] [Related]
3. Zoledronic acid targets chemo-resistant polyploid giant cancer cells.
Adibi R; Moein S; Gheisari Y
Sci Rep; 2023 Jan; 13(1):419. PubMed ID: 36624105
[TBL] [Abstract][Full Text] [Related]
4. Polyploid Giant Cancer Cells (PGCCs): The Evil Roots of Cancer.
Chen J; Niu N; Zhang J; Qi L; Shen W; Donkena KV; Feng Z; Liu J
Curr Cancer Drug Targets; 2019; 19(5):360-367. PubMed ID: 29968537
[TBL] [Abstract][Full Text] [Related]
5. Generation of cancer stem-like cells through the formation of polyploid giant cancer cells.
Zhang S; Mercado-Uribe I; Xing Z; Sun B; Kuang J; Liu J
Oncogene; 2014 Jan; 33(1):116-28. PubMed ID: 23524583
[TBL] [Abstract][Full Text] [Related]
6. Polyploid giant cancer cells and ovarian cancer: new insights into mitotic regulators and polyploidy†.
Richards JS; Candelaria NR; Lanz RB
Biol Reprod; 2021 Aug; 105(2):305-316. PubMed ID: 34037700
[TBL] [Abstract][Full Text] [Related]
7. Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.
Liberante FG; Lappin K; Barros EM; Vohhodina J; Grebien F; Savage KI; Mills KI
Sci Rep; 2019 Feb; 9(1):2678. PubMed ID: 30804405
[TBL] [Abstract][Full Text] [Related]
8. Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells.
Niu N; Mercado-Uribe I; Liu J
Oncogene; 2017 Aug; 36(34):4887-4900. PubMed ID: 28436947
[TBL] [Abstract][Full Text] [Related]
9. Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts.
Mupo A; Seiler M; Sathiaseelan V; Pance A; Yang Y; Agrawal AA; Iorio F; Bautista R; Pacharne S; Tzelepis K; Manes N; Wright P; Papaemmanuil E; Kent DG; Campbell PC; Buonamici S; Bolli N; Vassiliou GS
Leukemia; 2017 Mar; 31(3):720-727. PubMed ID: 27604819
[TBL] [Abstract][Full Text] [Related]
10. SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis.
Yang JY; Huo YM; Yang MW; Shen Y; Liu DJ; Fu XL; Tao LY; He RZ; Zhang JF; Hua R; Jiang SH; Sun YW; Liu W
Mol Oncol; 2021 Nov; 15(11):3076-3090. PubMed ID: 33932092
[TBL] [Abstract][Full Text] [Related]
11. Dormant cancer cells and polyploid giant cancer cells: The roots of cancer recurrence and metastasis.
Jiao Y; Yu Y; Zheng M; Yan M; Wang J; Zhang Y; Zhang S
Clin Transl Med; 2024 Feb; 14(2):e1567. PubMed ID: 38362620
[TBL] [Abstract][Full Text] [Related]
12. Alteration of SF3B1 and SRSF2 Genes in Myelodysplastic Syndromes Patients in Upper Northern Thailand.
Yimpak P; Tantiworawit A; Rattanathammethee T; Angsuchawan S; Laowatthanapong S; Tasuya W; Bumroongkit K
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1215-1221. PubMed ID: 31030497
[TBL] [Abstract][Full Text] [Related]
13. Investigating the Molecular Mechanism of H3B-8800: A Splicing Modulator Inducing Preferential Lethality in Spliceosome-Mutant Cancers.
Spinello A; Borišek J; Malcovati L; Magistrato A
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681880
[TBL] [Abstract][Full Text] [Related]
14. Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.
Obeng EA; Chappell RJ; Seiler M; Chen MC; Campagna DR; Schmidt PJ; Schneider RK; Lord AM; Wang L; Gambe RG; McConkey ME; Ali AM; Raza A; Yu L; Buonamici S; Smith PG; Mullally A; Wu CJ; Fleming MD; Ebert BL
Cancer Cell; 2016 Sep; 30(3):404-417. PubMed ID: 27622333
[TBL] [Abstract][Full Text] [Related]
15. Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations.
Choudhary GS; Pellagatti A; Agianian B; Smith MA; Bhagat TD; Gordon-Mitchell S; Sahu S; Pandey S; Shah N; Aluri S; Aggarwal R; Aminov S; Schwartz L; Steeples V; Booher RN; Ramachandra M; Samson M; Carbajal M; Pradhan K; Bowman TV; Pillai MM; Will B; Wickrema A; Shastri A; Bradley RK; Martell RE; Steidl UG; Gavathiotis E; Boultwood J; Starczynowski DT; Verma A
Elife; 2022 Aug; 11():. PubMed ID: 36040792
[TBL] [Abstract][Full Text] [Related]
16. PRL3 induces polypoid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse.
Thura M; Ye Z; Al-Aidaroos AQ; Xiong Q; Ong JY; Gupta A; Li J; Guo K; Ang KH; Zeng Q
Commun Biol; 2021 Jul; 4(1):923. PubMed ID: 34326464
[TBL] [Abstract][Full Text] [Related]
17. Intratumor Heterogeneity and Treatment Resistance of Solid Tumors with a Focus on Polyploid/Senescent Giant Cancer Cells (PGCCs).
Mirzayans R; Murray D
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511291
[TBL] [Abstract][Full Text] [Related]
18. Vimentin filaments drive migratory persistence in polyploidal cancer cells.
Xuan B; Ghosh D; Jiang J; Shao R; Dawson MR
Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26756-26765. PubMed ID: 33046658
[TBL] [Abstract][Full Text] [Related]
19. The SF3B1
Guo J; Li C; Fang Q; Liu Y; Wang D; Chen Y; Xie W; Zhang Y
J Exp Clin Cancer Res; 2022 Jan; 41(1):26. PubMed ID: 35039052
[TBL] [Abstract][Full Text] [Related]
20. SF3B1 mutant myelodysplastic syndrome: Recent advances.
Pellagatti A; Boultwood J
Adv Biol Regul; 2021 Jan; 79():100776. PubMed ID: 33358369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
